Literature DB >> 2414671

Mechanisms in multiple sclerosis.

B Waksman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2414671     DOI： 10.1038/318104a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  26 in total

1.  Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro.

Authors:  R P Saneto; A Altman; R L Knobler; H M Johnson; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 2.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

Authors:  K Selmaj; C S Raine; B Cannella; C F Brosnan
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

4.  Total lymphoid irradiation in chronic progressive multiple sclerosis.

Authors:  R Capra; N Marcianó; F Mattioli; V Di Monda; L A Vignolo; A Buffoli; E Micheletti; L Magno
Journal:  Ital J Neurol Sci       Date:  1992-03

5.  Immunological function of the blood-cerebrospinal fluid barrier.

Authors:  J A Nathanson; L L Chun
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Failure to find HTLV I and HIV I serum antibodies in MS patients.

Authors:  R Capra; F Mattioli; N Manca; G Scura
Journal:  Ital J Neurol Sci       Date:  1988-06

Review 7.  Cellular basis of T-cell autoreactivity in autoimmune diseases.

Authors:  C Carnaud; J F Bach
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

8.  Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  R W Melvold; D M Jokinen; S D Miller; M C Dal Canto; H L Lipton
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.

Authors:  A M Gautam; C B Lock; D E Smilek; C I Pearson; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis.

Authors:  R Shimonkevitz; C Colburn; J A Burnham; R S Murray; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.